Novartis targets Europe for next-generation AMD treatment

by Myles Hume

December 17, 2019

Home Tag Regeneron

Regeneron

Novartis is working with regulatory authorities to bring Beovu to DME patients.

FDA clears Novartis’ new treatment for nAMD

by Myles Hume

October 23, 2019

Novartis has secured US regulatory approval for Beovu, the company’s latest therapy for neovascular age-related macular degeneration (nAMD), following the ...

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Novartis targets Europe for next-generation AMD treatment

Regeneron

FDA clears Novartis’ new treatment for nAMD

Join our newsletter

Subscribe to our newsletter

About Insight

Popular Topics